Dysregulated Klotho and FGF23 signalling aggravates vascular remodelling in age-related pulmonary hypertension
Cardiovascular Research · 28.04.2026 · 122 (6) · 764-777
DOI: 10.1093/cvr/cvag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 27.02.2026. Verfasst von Paul-Lennard Perret und 20 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, Berlin 10117, Ge…. Hauptthemen laut MEDLINE: Vascular Remodeling, Fibroblast Growth Factors, Glucuronidase, Hypertension, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Berlin Institute of Health, Deutsche Forschungsgemeinschaft, Corona-Stiftung Grant.
Abstract (Originalsprache)
Aims
Pulmonary arterial hypertension (PAH) is a chronic condition of elevated pulmonary arterial pressure caused by vascular remodelling due to increased proliferation of pulmonary arterial smooth muscle cells (PASMC). Initially described as a disease primarily affecting young women, it now increasingly affects the elderly. Age-related pathomechanisms of PAH remain, however, unclear. In a translational approach combining preclinical disease models and analyses of human cohorts, we probed for a role of the anti-ageing protein Klotho, which acts as a co-receptor for fibroblast growth factor 23 (FGF23) in the pathogenesis of PAH. Methods and results Mice aged 114–117 weeks showed moderate spontaneous PAH with right ventricular (RV) hypertrophy and dysfunction relative to young mice aged < 40 weeks. This effect was further pronounced upon hypoxic exposure (10% O2) for 14 days. Histological sections showed pulmonary vascular wall thickening of small pulmonary arterioles. Similar findings were obtained in mice with a partial Klotho deficiency (kl/+) that developed RV systolic pressures (RVSP) of 72.58 ± 3.3 mmHg within two weeks of hypoxia. Aged mice and kl/+ mice had elevated plasma levels of FGF23, further amplified by hypoxic exposure. ELISA-based measurements in serum of patients from a cross-sectional study with PAH aged 60 years or older confirmed an increase in circulatory FGF23. Immunohistochemistry staining of lung tissue showed increased proliferative activity of PASMC in kl/+ mice, and recombinant FGF23 elevated proliferative activity of PASMC in vitro. The hyperproliferative response to FGF23 was prevented by siRNA-mediated knockdown of fibroblast growth factor receptor 1 in PASMC. In kl/+ mice, FGF23 neutralisation using an anti-FGF23 antibody reduced RVSP, improved RV dysfunction and RV hypertrophy and prevented pulmonary vascular remodelling.
Conclusion
Our findings identify the accumulation of FGF23 as novel mechanism of pulmonary vascular remodeling in PAH. Targeting dysregulated Klotho/FGF23 signalling may present a promising therapeutic strategy in elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, Berlin 10117, Germany.
- Institute of Physiology, Charité University Medicine Berlin, corporate Member of Freie University Berlin and Humboldt-University Charitéplatz 1, Berlin 10117, Germany.
- DZHK: German Center for Cardiovascular Research, partner Site Berlin, Berlin, Germany.
- Berlin Institute of Health (BIH), Berlin, Germany.
- Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Augustenburger Platz 1, Berlin 13353, Germany.
- Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nutethal 14558, Germany.
ORCID-Profile: Jana Grune
Förderung
- Berlin Institute of Health
- Deutsche Forschungsgemeinschaft
- Corona-Stiftung Grant
- German Society for Cardiology
- Deutsche Stiftung für Herzforschung
- German Center for Cardiovascular Research
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Perret, P. L., Kim, J. H., Winkler, A., Ott, C., Bintig, W., Funk-Hilsdorf, T. C., Asmus, E., Simmons, S., Michalick, L., Solymosi, P. D., Knaus, P., Herpich, C., Norman, K., Müller-Werdan, U., Foris, V., Kovacs, G., Kuro-O, M., Grune, T., Voelkl, J., …, & Kuebler, W. M. (2026). Dysregulated Klotho and FGF23 signalling aggravates vascular remodelling in age-related pulmonary hypertension. Cardiovascular Research, 122(6), 764-777. https://doi.org/10.1093/cvr/cvag048
Vancouver
Perret PL, Kim JH, Winkler A, Ott C, Bintig W, Funk-Hilsdorf TC, et al. Dysregulated Klotho and FGF23 signalling aggravates vascular remodelling in age-related pulmonary hypertension. Cardiovascular Research. 2026;122(6):764-777. doi:10.1093/cvr/cvag048
BibTeX
@article{Perret2026,
author = {Perret, Paul-Lennard and Kim, Jonathan H and Winkler, Annika and Ott, Christiane and Bintig, Willem and Funk-Hilsdorf, Teresa C and Asmus, Erik and Simmons, Szandor and Michalick, Laura and Solymosi, Philip D and Knaus, Petra and Herpich, Catrin and Norman, Kristina and Müller-Werdan, Ursula and Foris, Vasile and Kovacs, Gabor and Kuro-O, Makoto and Grune, Tilman and Voelkl, Jakob and Grune, Jana and Kuebler, Wolfgang M},
title = {Dysregulated Klotho and FGF23 signalling aggravates vascular remodelling in age-related pulmonary hypertension},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {6},
pages = {764--777},
doi = {10.1093/cvr/cvag048}
}
EUVIMED